Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea for Unresectable Meningioma
NCT00003590Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Nov 1998
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydroxyurea in meningioma, sponsored by SWOG Cancer Research Network. Primary endpoint: Partial and Complete Response Rates at 2 years. Started Nov 1998; status: completed.
02
Drugs
hydroxyurea
03
Conditions
meningioma
Beyond the preview
Go deeper on NCT00003590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003590.